Thallion looking awesome...
By the trial design presented to FDA, we can now surely understand that early efficacy (8 weeks and 16 weeks) measurements were more than satisfactory.
Unless, something changes during the 5th and 6th month, we have a winner here. A winner.
Judging by lateness in trial, we move toward awesome data.